Literature DB >> 11706967

Human herpesvirus 6 limbic encephalitis after stem cell transplantation.

M S Wainwright1, P L Martin, R P Morse, M Lacaze, J M Provenzale, R E Coleman, M A Morgan, C Hulette, J Kurtzberg, C Bushnell, L Epstein, D V Lewis.   

Abstract

Central nervous system complications are common in stem cell transplant recipients, but selective involvement of the medial temporal area is unusual. The 5 patients reported here presented after stem cell transplantation with increased hippocampal T2 signal on magnetic resonance imaging and increased hippocampal glucose uptake on [F-18]fluorodeoxyglucose-positron emission tomography (FDG-PET) associated with short-term memory loss, insomnia, and temporal lobe electrographic seizure activity. The initial scalp electroencephalograms (EEGs) failed to detect seizure activity in these patients, although the memory dysfunction along with the magnetic resonance imaging and FDG-PET findings suggested subcortical seizure activity. However, extended EEG monitoring revealed repetitive temporal lobe electrographic seizure activity. Follow-up MRIs in 2 patients and postmortem findings on 1 patient suggested that hippocampal sclerosis had developed following the clinical syndrome. Cerebrospinal fluid studies revealed the presence of human herpesvirus 6, variant B, DNA in all of 3 patients who had lumbar punctures. Immunohistochemical staining for the P41 and P101 human herpesvirus 6 protein antigens showed numerous immunoreactive astrocytes and neurons in the hippocampus of 1 of the patients who died from other causes. Because of its subtle clinical presentation, this syndrome may be underrecognized, but can be diagnosed with appropriate magnetic resonance imaging techniques, EEG monitoring, and cerebrospinal fluid viral studies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11706967     DOI: 10.1002/ana.1251

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  48 in total

1.  Febrile Seizures and Mesial Temporal Sclerosis.

Authors:  Shlomo Shinnar
Journal:  Epilepsy Curr       Date:  2003-07       Impact factor: 7.500

2.  Analysis of a neutralizing antibody for human herpesvirus 6B reveals a role for glycoprotein Q1 in viral entry.

Authors:  Akiko Kawabata; Hiroko Oyaizu; Takahiro Maeki; Huamin Tang; Koichi Yamanishi; Yasuko Mori
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

3.  MR imaging of human herpesvirus-6 encephalopathy after hematopoietic stem cell transplantation in adults.

Authors:  T Noguchi; F Mihara; T Yoshiura; O Togao; K Atsumi; T Matsuura; T Kuroiwa; H Honda
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

4.  The case for immunomodulatory approaches in treating HSV encephalitis.

Authors:  Chandran Ramakrishna; Harry Openshaw; Edouard M Cantin
Journal:  Future Virol       Date:  2013-03-01       Impact factor: 1.831

5.  Diagnostic Clues to Human Herpesvirus 6 Encephalitis and Wernicke Encephalopathy After Pediatric Hematopoietic Cell Transplantation.

Authors:  Zsila Sadighi; Noah D Sabin; Randall Hayden; Elizabeth Stewart; Asha Pillai
Journal:  J Child Neurol       Date:  2015-01-06       Impact factor: 1.987

Review 6.  Autoimmune encephalopathies.

Authors:  Frank Leypoldt; Thaís Armangue; Josep Dalmau
Journal:  Ann N Y Acad Sci       Date:  2014-10-14       Impact factor: 5.691

Review 7.  Neuroimaging of herpesvirus infections in children.

Authors:  Henry J Baskin; Gary Hedlund
Journal:  Pediatr Radiol       Date:  2007-05-22

8.  A patient with encephalitis associated with NMDA receptor antibodies.

Authors:  Lauren H Sansing; Erdem Tüzün; Melissa W Ko; Jennifer Baccon; David R Lynch; Josep Dalmau
Journal:  Nat Clin Pract Neurol       Date:  2007-05

9.  Limbic encephalitis and related cortical syndromes.

Authors:  Ignacio Rubio-Agusti; Miguel Salavert; Luis Bataller
Journal:  Curr Treat Options Neurol       Date:  2013-04       Impact factor: 3.598

10.  Human herpesvirus type 6 indirectly enhances oligodendrocyte cell death.

Authors:  Hong Kong; Quinton Baerbig; Laine Duncan; Nick Shepel; Michael Mayne
Journal:  J Neurovirol       Date:  2003-10       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.